Venegas Alen supplement health benefit claims prohibited by FTC in proposed settlement.
This article was originally published in The Tan Sheet
Executive Summary
VENEGAS ALEN SUPPLEMENT HEALTH CLAIMS PROHIBITED BY FTC until the company obtains competent and reliable substantiation for its dietary supplement product, the Federal Trade Commission said in a proposed settlement agreement released Oct. 29. Brooklyn, N.Y.-based Venegas was making a number of "unsubstantiated" health claims for Alen, a powdered nutritional supplement containing wheat germ, wheat bran, soybean extract and seaweed extract, primarily in New York City in such publications as El Diario, a Spanish-language newspaper, and on a local Spanish television station, according to FTC.